Pilot clinical trial of macimorelin to assess safety and efficacy in patients with cancer cachexia
Abstract
Cancer cachexia is associated with reduced body weight, appetite and quality of life (QOL) with no approved treatments. Growth hormone secretagogues like macimorelin have potential to mitigate these effects.
Document Details
- Document Type
- Pub Defense Publication
- Publication Date
- Mar 01, 2023
- Source ID
- 10.1002/jcsm.13191
Entities
People
- Ellen A. Schur
- José M. Garcia
- Lindsey J Anderson
- Marco Marcelli
- Megan Herodes
- Nicola Ammer
- Ramiro Salas
- Samuel Shober
- Solomon A. Graf
Organizations
- Baylor College of Medicine
- Congressionally Directed Medical Research Programs
- Fred Hutchinson Cancer Center
- Menninger Foundation
- Michael E. DeBakey Veterans Affairs Medical Center in Houston
- National Institutes of Health
- United States Department of Veterans Affairs
- University of Washington